Galera Therapeutics Inc

GRTX04 Jun 2024
Healthcare
$0.16
-0.33 (-32.59%)
Lowest Today
$0.14
Highest Today
$0.17
Today’s Open
$0.16
Prev. Close
$0.22
52 Week High
$3.59
52 Week Low
$0.09
To Invest in Galera Therapeutics Inc

Galera Therapeutics Inc

Healthcare
GRTX04 Jun 2024
-0.33 (-32.59%)
1M
3M
6M
1Y
5Y
Low
$0.14
Day’s Range
High
$0.17
0.14
52 Week Low
$0.08
52-Week Range
52 Week High
$3.59
0.08
1 Day
-
1 Week
-
1 month return
-
3 month return
-
6 month return
-36.39%
1 Year return
-
3 Years return
-
5 Years return
-
10 Years return
-
Institutional Holdings
GSA Capital Partners LLP
6.68
Blackstone Inc
3.09
abrdn PLC
1.65
Vanguard Group Inc
0.82
Vanguard Institutional Extnd Mkt Idx Tr
0.82
Geode Capital Management, LLC
0.81
BlackRock Inc
0.66

Market Status

Fundamentals
Market Cap
11.7 mln
PB Ratio
29.39
PE Ratio
0
Enterprise Value
150.5 mln
Total Assets
26.14 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Galera Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule dismutase mimetic for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and for patients with HNC undergoing standard-of-care radiotherapy. It also develops rucosopasem manganese (rucosopasem) to augment the anti-cancer efficacy of stereotactic body radiation therapy in patients with non-small cell lung cancer and locally advanced pancreatic cancer. The company was incorporated in 2012 and is based in Malvern, Pennsylvania.
Organisation
Galera Therapeutics Inc
Employees
7
Industry
Biotechnology
CEO
Dr. J. Mel Sorensen M.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities